Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study) ; volume:3 ; number:1 ; day:22 ; month:12 ; year:2015 ; pages:129-141 ; date:6.2016
Rheumatology and therapy ; 3, Heft 1 (22.12.2015), 129-141, 6.2016
- Creator
-
Koike, Takao
- Contributor
-
Harigai, Masayoshi
Ishiguro, Naoki
Inokuma, Shigeko
Takei, Syuji
Takeuchi, Tsutomu
Yamanaka, Hisashi
Takasaki, Yoshinari
Mimori, Tsuneyo
Hiramatsu, Katsutoshi
Komatsu, Shuichi
Tanaka, Yoshiya
SpringerLink (Online service)
- DOI
-
10.1007/s40744-015-0023-x
- URN
-
urn:nbn:de:1111-2016062210675
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koike, Takao
- Harigai, Masayoshi
- Ishiguro, Naoki
- Inokuma, Shigeko
- Takei, Syuji
- Takeuchi, Tsutomu
- Yamanaka, Hisashi
- Takasaki, Yoshinari
- Mimori, Tsuneyo
- Hiramatsu, Katsutoshi
- Komatsu, Shuichi
- Tanaka, Yoshiya
- SpringerLink (Online service)
Other Objects (12)
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Rheumatoid arthritis
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases
Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Rheumatoid arthritis
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases
Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Rheumatoid arthritis
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases
Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry